Overview. A new discovery phase for antitumor drugs?
Gewirtz
D A
DA
Department of Medicine, Virginia Commonwealth University/Medical College of Virginia, PO Box 980230, Richmond, VA, USA. gewirtz@hsc.vcu.edu
D020533:Angiogenesis Inhibitors / Q000627:therapeutic use; D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D015316:Genetic Therapy; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy* / Q000235:genetics; D015398:Signal Transduction / Q000187:drug effects
D020533:Angiogenesis Inhibitors; D000970:Antineoplastic Agents